Use of NAALADase activity to identify prostate cancer and benign prostatic hyperplasia
US5981209A · kind A · utility
25Cited by
63References
42Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 4, 1997 |
| Grant date | Nov 9, 1999 |
| Priority date | — |
| Expiry date | Dec 4, 2017 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/975
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to novel methods and kits for quantitating N-Acetylated .alpha.-Linked Acidic Dipeptidase (NAALADase) enzyme activity in biological samples, including prostate biopsies, seminal fluid, ejaculate, prostatic fluid, blood, saliva, and urine, for the purpose of identifying and differentiating between prostate carcinoma, benign prostatic hyperplasia, and normal prostate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.